SCHEMBL27407274

SCHEMBL27407274

Cc1ccc(C(C)CCc2cccc(C)n2)nc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CXCR4 P61073 1/20 0.34
▸ GRM5 P41594 3/20 0.33
▸ HDAC1 Q13547 2/20 0.33
▸ HDAC6 Q9UBN7 2/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ PDE10A Q9Y233 1/20 0.33
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ NOS1 P29475 2/20 0.32
▸ NOS2 P35228 2/20 0.32
▸ XIAP P98170 1/20 0.32
▸ BIRC2 Q13490 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ KEAP1 Q14145 1/20 0.32
▸ NFE2L2 Q16236 1/20 0.32
▸ HDAC4 P56524 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18672324 0.90 NOS1 (0.34) CXCR4HDAC6PDE10ANOS1NOS2
SCHEMBL19369541 0.77 PDE10A (0.43) SMN1; SMN2GRM5HDAC6PDE10ACYP3A4
SCHEMBL19132984 0.75 KCNH2 (0.38) GRM5ALDH1A1
SCHEMBL25895511 0.75 NOS3 (0.35) CXCR4HDAC6NOS2XIAPBIRC2
SCHEMBL11991705 0.74 NOS2 (0.44) SMN1; SMN2CXCR4NOS1NOS2KDM4E
SCHEMBL17828000 0.73 CCR1 (0.40) HDAC6NOS2KDM4EALDH1A1ESR1
SCHEMBL21078327 0.70 KDM4E (0.40) SMN1; SMN2CXCR4HDAC6CYP2C9CYP2C19
SCHEMBL22450849 0.70 RAB9A (0.38) SMN1; SMN2HDAC6NOS2XIAPBIRC2
SCHEMBL17828006 0.70 CCR1 (0.34) SMN1; SMN2HDAC6NOS2KDM4EALDH1A1
SCHEMBL24916774 0.70 CCR1 (0.52) SMN1; SMN2GRM5PDE10ANOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209000-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS INTELLIKINE LLC 2024-06-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209000-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS PIK3CA, PIK3CG, PIK3CD SMN1; SMN2 2664/4885CXCR4 1823/4885GRM5 4010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback